Sponsor
Granite Bio AG
Aeschenvorstadt 36, 4051
About the sponsor
Granite Bio AG focuses on ulcerative colitis, with clinical research centered on immune-mediated intestinal inflammation and the development of therapies for patients with active disease.
- Ulcerative colitis
- Immune-mediated inflammation
- Gastrointestinal disease
The sponsor’s current clinical activity is concentrated in Basel, Switzerland, with all active studies directed toward this single therapeutic area.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.